Tag: metastatic_cancer
-
Experimental Drug Doubles Survival for Metastatic Pancreatic Cancer
A new experimental drug has demonstrated remarkable success, doubling the median survival rate for patients with metastatic pancreatic cancer. This breakthrough offers a dramatic shift in treatment, bringing renewed hope to those affected.
HealthBusinessScience & TechnologyEntertainmentMedical ScienceEconomyEmployment and LaborEducation Pancreatic CancerMetastatic CancerExperimental DrugCancer TreatmentMedical ResearchSurvival RateOncology